High Performance Liquid Chromatography HPLC Device

High Performance Liquid Chromatography (HPLC) Device Market Outlook

The global High Performance Liquid Chromatography (HPLC) device market is projected to reach approximately USD 4.8 billion by 2035, registering a compound annual growth rate (CAGR) of around 6.5% from 2025 to 2035. This growth is driven by the increasing demand for high-quality analytical solutions across various industries, including pharmaceuticals, biotechnology, and environmental testing. Additionally, advancements in HPLC technology, such as better sensitivity, speed, and resolution, are contributing to the heightened adoption of HPLC systems. The pharmaceutical industry, in particular, is experiencing a surge in demand for HPLC devices due to the stringent regulations for drug testing and quality control. Furthermore, the rise in R&D activities in healthcare and environmental sectors is expected to bolster the market for HPLC devices significantly.

Growth Factor of the Market

One of the primary growth factors for the HPLC device market is the increasing prevalence of chronic diseases, which necessitates extensive research and drug development processes. Advances in technology that enhance the performance and efficiency of HPLC systems also play a crucial role in driving market growth. Innovative features such as automated sample handling, improved data management systems, and enhanced method development capabilities allow researchers to conduct more efficient analyses. Moreover, the growing trend of personalized medicine is expected to further fuel the demand for HPLC devices, as customized treatments require precise analytical measurements of drug concentrations. The expansion of pharmaceutical and biotechnology industries, particularly in emerging economies, is also a significant contributor to the market's growth trajectory. Finally, the rising awareness of environmental concerns is leading to increased testing for pollutants and hazardous substances, thereby creating additional opportunities for HPLC applications in environmental analysis.

Key Highlights of the Market

• The global HPLC device market is expected to grow at a CAGR of 6.5% from 2025 to 2035.
• Pharmaceutical applications dominated the market, contributing significantly to overall revenue.
• Technological advancements continue to drive the development of innovative HPLC systems.
• Asia Pacific is anticipated to witness the highest growth rate in the coming years.
• The increasing focus on environmental safety and quality control is expanding the use of HPLC in environmental analysis.

By Product Type

Single Pump HPLC Systems:

Single pump HPLC systems are popular due to their simplicity and cost-effectiveness in routine analytical applications. These systems are typically used for straightforward separations and analyses, making them suitable for various sectors, including pharmaceuticals and food testing. The design of single pump systems allows for continuous solvent flow, which is essential for maintaining consistent pressure during the chromatographic process. As such, these units serve as a foundational technology for many laboratories. The ease of maintenance and reduced operational costs associated with single pump systems further contribute to their adoption, especially among smaller laboratories and academic institutions where budgets may be limited.

Dual Pump HPLC Systems:

Dual pump HPLC systems offer enhanced versatility and performance compared to their single pump counterparts. This configuration allows for gradient elution, which is particularly valuable for complex sample mixtures that require varying solvent compositions throughout the separation process. The dual pump systems are increasingly utilized in research environments and industries that demand high-resolution separations and faster analysis times. Furthermore, the ability to automate sample processing and integrate with other analytical techniques, such as mass spectrometry, significantly enhances the utility of dual pump systems in laboratories. As research and development efforts continue to grow, the demand for dual pump configurations is expected to rise, driven by their ability to meet sophisticated analytical requirements.

Preparative HPLC Systems:

Preparative HPLC systems are specifically designed for the large-scale separation and purification of compounds, making them integral to drug development and production processes. These systems can handle larger sample volumes and provide high recovery rates, which are critical for isolating active pharmaceutical ingredients (APIs) and other valuable compounds. The increasing need for purity and yield in biopharmaceutical manufacturing is propelling the market for preparative HPLC systems. Additionally, advancements in technology have led to the development of more efficient preparative systems that can reduce processing times while maintaining the integrity of sensitive compounds. As a result, these systems are becoming increasingly popular within pharmaceutical and biotechnology sectors where large-scale purification is essential.

Analytical HPLC Systems:

Analytical HPLC systems play a vital role in quality control and assurance processes across various industries. These systems are designed to deliver precise and reproducible results for the analysis of small quantities of samples. They are widely used for stability testing, impurity profiling, and formulation assessments in drug development. With the rising regulatory pressures on the pharmaceutical industry for stringent testing protocols, the demand for reliable analytical HPLC systems continues to increase. Furthermore, the integration of advanced detection technologies, such as UV-Vis and fluorescence detectors, is enhancing the capabilities of analytical HPLC systems, allowing for more comprehensive analyses. As the need for regulatory compliance and high-quality products persists, analytical HPLC systems remain critical tools for laboratories globally.

Others:

This category encompasses various niche HPLC systems and configurations that cater to specialized applications not covered by the primary types. Examples include ultra-high-performance liquid chromatography (UHPLC) systems, which offer higher resolution and speed compared to conventional HPLC, and compact HPLC systems designed for specific applications in fieldwork or remote locations. These systems are increasingly being adopted in laboratories focused on cutting-edge research and development, as well as in industries requiring rapid and efficient analysis. The growing emphasis on miniaturization and portability in laboratory equipment is also driving innovation in this segment, making "others" a noteworthy category within the broader HPLC device market.

By Application

Pharmaceuticals:

The pharmaceutical sector is the largest application area for HPLC devices, driven by the need for rigorous testing and quality assurance in drug development. HPLC plays a crucial role in the analysis of active pharmaceutical ingredients (APIs), formulation studies, and stability testing, ensuring that products meet stringent regulatory requirements. Moreover, the increasing focus on personalized medicine necessitates advanced analytical techniques to assess drug interactions and efficacy in individual patients. As pharmaceutical companies invest in research and development to bring new therapies to market, the reliance on HPLC technology for comprehensive testing and quality control is expected to remain robust.

Biotechnology:

In biotechnology, HPLC technology is employed to analyze biomolecules, including proteins, peptides, and nucleic acids. The ability to separate and purify complex biological mixtures is essential for various biotechnological applications, such as monoclonal antibody production and recombinant protein manufacturing. As biopharmaceuticals gain traction in the healthcare market, the demand for efficient and reliable HPLC systems to support these processes is increasing. Furthermore, advancements in HPLC technology, such as the development of affinity column chromatography, are enhancing the analytical capabilities for biopharmaceutical applications. Therefore, the biotechnology sector is expected to see significant growth in the adoption of HPLC devices in the coming years.

Clinical Diagnostics:

Clinical diagnostics is another vital application for HPLC systems, particularly in the analysis of biological samples for disease detection and monitoring. HPLC is utilized for various tests, including therapeutic drug monitoring, toxicology screening, and metabolic profiling. The increasing prevalence of chronic diseases, coupled with the growing emphasis on early detection and personalized treatment strategies, is driving the demand for HPLC devices in clinical laboratories. Moreover, the integration of HPLC with other diagnostic technologies, such as mass spectrometry, has expanded its utility in clinical settings. As healthcare systems evolve to prioritize precision medicine, the role of HPLC in clinical diagnostics is expected to grow significantly.

Environmental Analysis:

Environmental analysis is an emerging application area for HPLC devices, as there is a growing need to monitor pollutants and hazardous substances in water, soil, and air. Regulatory agencies are increasingly imposing stringent guidelines for environmental quality, necessitating accurate and efficient analytical methods for detecting contaminants. HPLC systems are well-suited for analyzing complex environmental samples, providing the sensitivity and specificity required for accurate assessments. The rising global awareness of environmental issues, coupled with regulatory pressures, is driving the demand for HPLC devices in environmental testing laboratories. As more industries and governments prioritize environmental protection, the market for HPLC systems in this sector is poised for substantial growth.

Others:

In addition to the primary application areas, "others" encompasses various niche applications of HPLC technology across different industries. This may include food and beverage testing for contaminants, quality control in cosmetic manufacturing, or analytical assessments in chemical research. The versatility of HPLC systems allows them to adapt to various analytical needs, making them indispensable in laboratories that require precise separation and analysis of complex mixtures. As industries increasingly seek to ensure product safety and quality, the demand for HPLC devices across these lesser-known applications is also expected to rise significantly.

By Distribution Channel

Direct Sales:

Direct sales of HPLC systems involve manufacturers selling their products directly to end-users, often providing a more personalized purchasing experience. This channel allows manufacturers to establish closer relationships with customers, enabling them to better understand specific needs and offer tailored solutions. Additionally, direct sales often include post-purchase support and services, such as installation, training, and maintenance, which are critical for ensuring optimal system performance. This approach fosters customer loyalty and long-term partnerships, making it a favorable distribution channel for many HPLC manufacturers. As customer demands evolve, direct sales channels are expected to play an increasingly significant role in the HPLC device market.

Distributor Sales:

Distributor sales of HPLC systems involve third-party intermediaries who represent multiple manufacturers and offer a range of products to end-users. This channel provides customers with access to a broader selection of HPLC devices and related products, along with competitive pricing options. Distributors often have established networks and local market knowledge, which can facilitate quicker and more efficient procurement processes for laboratories. Furthermore, many distributors provide additional services, including technical support and training, to assist customers in maximizing the performance of their HPLC systems. As the market becomes more competitive, distributor sales are likely to maintain a significant presence, particularly in regions where direct sales may be less feasible.

By End User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies represent the largest category of end-users for HPLC devices. These organizations rely on HPLC technology for a wide array of applications, ranging from drug formulation and stability testing to quality control and regulatory compliance. The rigorous requirements for product safety and efficacy in these industries necessitate the use of advanced analytical techniques, with HPLC being a cornerstone of laboratory operations. As the pharmaceutical and biopharmaceutical sectors continue to expand, the demand for reliable and efficient HPLC systems is anticipated to grow, driven by the need for high-throughput analyses and enhanced productivity in research and development.

Academic & Research Institutes:

Academic and research institutes are significant end-users of HPLC technology, utilizing these devices for a variety of scientific investigations and educational purposes. These institutions often focus on fundamental research, exploring new compounds and methodologies that contribute to advancements in various fields. The versatility of HPLC systems makes them suitable for diverse applications, including organic chemistry, environmental science, and biochemistry. Additionally, the integration of HPLC in educational settings provides students with hands-on experience in analytical techniques, preparing them for future careers in academia and industry. As research funding continues to grow, the role of HPLC in academic and research laboratories is expected to remain robust.

Hospitals & Clinics:

Hospitals and clinics are increasingly adopting HPLC technology for clinical diagnostics and laboratory testing. HPLC systems are crucial for therapeutic drug monitoring, toxicology screenings, and metabolic profiling, providing healthcare professionals with vital information to guide patient care. The growing emphasis on personalized medicine and targeted therapies necessitates accurate and reliable analytical methods, propelling the demand for HPLC devices in clinical settings. Furthermore, the increasing prevalence of chronic diseases, coupled with the rising demand for efficient diagnostic processes, is likely to further enhance the role of HPLC in hospitals and clinics. As healthcare continues to evolve, HPLC systems will be essential tools for improving patient outcomes and ensuring high standards of care.

Others:

The "others" category encompasses a range of additional end-users that utilize HPLC technology for specialized applications. This may include industries such as food and beverage testing, environmental agencies, and cosmetic manufacturers. Each of these sectors requires precise analytical measurements to ensure product quality, safety, and regulatory compliance. The versatility of HPLC systems allows them to be adapted for various analytical needs, making them valuable assets across multiple industries. As global standards for quality and safety continue to tighten, the demand for HPLC devices among these diverse end-users is expected to grow significantly, contributing to the overall expansion of the market.

By Region

The North American region holds a prominent share of the global HPLC device market, primarily due to the presence of a well-established pharmaceutical and biotechnology industry. The region's market is projected to reach approximately USD 1.6 billion by 2035, with a CAGR of 5.8% during the forecast period. The strong focus on research and development, supported by significant investments from both public and private sectors, is driving the demand for advanced analytical techniques, including HPLC. Moreover, the increasing prevalence of chronic diseases and the need for effective diagnostic methods are further propelling the growth of the HPLC market in North America.

In Europe, the HPLC device market is also witnessing substantial growth, fueled by the stringent regulatory requirements for pharmaceutical and biopharmaceutical products. The European market is expected to reach around USD 1.3 billion by 2035, with a CAGR of 6.0% from 2025 to 2035. Factors such as the growing emphasis on environmental testing and the expansion of research institutions in the region contribute to the increasing adoption of HPLC technology. As regulatory agencies continue to implement rigorous testing protocols, the demand for high-performance liquid chromatography systems in Europe is anticipated to remain strong.

Opportunities

The HPLC device market is poised to benefit from a variety of opportunities stemming from technological advancements and evolving industry needs. One significant opportunity lies in the integration of artificial intelligence and machine learning in HPLC systems, which can enhance data analysis and instrument performance. By leveraging these technologies, laboratories can optimize their analytical processes and improve the accuracy and speed of results. Additionally, the growing trend of automation in laboratories presents opportunities for HPLC manufacturers to develop automated systems that streamline workflows and reduce manual intervention, further enhancing productivity. As laboratories strive for greater efficiency and precision in their analyses, the demand for advanced HPLC devices equipped with innovative features is expected to increase.

Another promising opportunity for the HPLC device market is the rising demand for green chemistry practices. There is an increasing awareness of the environmental impact of traditional HPLC processes, leading to a shift towards more sustainable practices. Manufacturers are responding by developing eco-friendly solvents, reducing waste, and optimizing analytical methods to minimize the environmental footprint of HPLC applications. Furthermore, the growing interest in alternative applications, such as micro-HPLC and high-throughput screening, presents avenues for innovation and market expansion. As industries prioritize sustainability and environmental safety, the HPLC market is well-positioned to adapt and thrive in this evolving landscape.

Threats

Despite the promising growth prospects for the HPLC device market, several threats could hinder its advancement. One significant threat is the rapid pace of technological advancements in analytical techniques, which poses a challenge to traditional HPLC systems. Emerging technologies, such as ultra-high-performance liquid chromatography (UHPLC) and other separation techniques, may offer superior performance and efficiency, potentially displacing conventional HPLC systems in certain applications. As research institutions and laboratories increasingly adopt these new technologies, manufacturers of traditional HPLC devices must innovate continuously to remain competitive and relevant in the marketplace. Moreover, the high costs associated with advanced HPLC systems could deter smaller laboratories and academic institutions from making significant investments, limiting market growth in specific segments.

Another potential threat arises from regulatory challenges and changing compliance requirements across various industries. As regulatory agencies implement stricter guidelines for product testing and quality control, laboratories may face increased pressure to adopt advanced analytical solutions that meet these new standards. Failure to comply with evolving regulations could result in significant financial penalties and reputational damage for companies, affecting their willingness to invest in HPLC technology. Furthermore, supply chain disruptions and fluctuations in raw material costs can pose challenges for HPLC manufacturers, impacting their ability to deliver products on time and within budget. The combination of these factors could create an unstable market environment, hindering growth opportunities.

Competitor Outlook

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Shimadzu Corporation
• Hitachi High-Technologies
• JASCO Corporation
• Biotage AB
• Knauer Wissenschaftliche Geräte GmbH
• Merck KGaA
• SCIEX
• VWR International
• Gilson, Inc.
• Bruker Corporation
• Hewlett Packard Enterprise

The overall competitive landscape of the HPLC device market is characterized by the presence of several key players that are continuously innovating to enhance their product offerings. These companies compete on various fronts, including technological advancements, pricing strategies, and customer service. The market is seeing a growing trend toward consolidation, with larger companies acquiring smaller firms to broaden their expertise and product portfolios. Additionally, companies are investing heavily in research and development to create next-generation HPLC systems that cater to the changing needs of their customers. Collaborative partnerships and alliances among industry stakeholders are also emerging as a strategy to leverage complementary strengths and expand market reach.

Agilent Technologies, a leader in analytical instrumentation, is known for its cutting-edge HPLC systems that integrate advanced technology for seamless operation and data management. The company emphasizes innovation, continuously developing new products to address emerging analytical challenges. Similarly, Thermo Fisher Scientific offers a comprehensive range of HPLC systems tailored to various applications, from routine analyses to complex research. The company is committed to enhancing user experience through integrated solutions that provide robust performance and reliability across diverse laboratory environments.

Waters Corporation is another major player in the HPLC market, recognized for its innovative technologies and high-performance liquid chromatography systems. The company's focus on providing solutions for pharmaceutical, biopharmaceutical, and environmental applications has positioned it as a leader in the industry. Additionally, Shimadzu Corporation is known for its robust HPLC systems that cater to a wide range of industries, including pharmaceuticals, food and beverage, and environmental analysis. The company's commitment to quality and customer satisfaction is evident in its extensive support services and comprehensive training programs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 SCIEX
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Biotage AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Gilson, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 JASCO Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 VWR International
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bruker Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Waters Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Agilent Technologies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Shimadzu Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hitachi High-Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hewlett Packard Enterprise
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Knauer Wissenschaftliche Geräte GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 High Performance Liquid Chromatography HPLC Device Market, By End User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Academic & Research Institutes
    • 6.1.3 Hospitals & Clinics
    • 6.1.4 Others
  • 6.2 High Performance Liquid Chromatography HPLC Device Market, By Application
    • 6.2.1 Pharmaceuticals
    • 6.2.2 Biotechnology
    • 6.2.3 Clinical Diagnostics
    • 6.2.4 Environmental Analysis
    • 6.2.5 Others
  • 6.3 High Performance Liquid Chromatography HPLC Device Market, By Product Type
    • 6.3.1 Single Pump HPLC Systems
    • 6.3.2 Dual Pump HPLC Systems
    • 6.3.3 Preparative HPLC Systems
    • 6.3.4 Analytical HPLC Systems
    • 6.3.5 Others
  • 6.4 High Performance Liquid Chromatography HPLC Device Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 High Performance Liquid Chromatography HPLC Device Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global High Performance Liquid Chromatography HPLC Device market is categorized based on

By Product Type

• Single Pump HPLC Systems
• Dual Pump HPLC Systems
• Preparative HPLC Systems
• Analytical HPLC Systems
• Others

By Application

• Pharmaceuticals
• Biotechnology
• Clinical Diagnostics
• Environmental Analysis
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Clinics
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• PerkinElmer
• Shimadzu Corporation
• Hitachi High-Technologies
• JASCO Corporation
• Biotage AB
• Knauer Wissenschaftliche Geräte GmbH
• Merck KGaA
• SCIEX
• VWR International
• Gilson, Inc.
• Bruker Corporation
• Hewlett Packard Enterprise